DAVID A. FELLOWS - 01 Jul 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for David A Fellows
Issuer symbol
TERN
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
02 Jul 2024, 18:36:12 UTC
Previous filing
14 Jun 2024
Next filing
03 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +8,183 $0.000000 8,183 01 Jul 2024 Common Stock 8,183 $6.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $35,000 for the third and fourth quarters of 2024.
F2 The option will vest as to 1/6th of the total shares subject thereto on each monthly anniversary of the date of grant, such that 100% of the shares subject to the option will be fully vested on January 1, 2025.